P. Gisondi, F. Loconsole, P. Raimondo, and R. Ravasio, “Cost per responder for risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis in Italy”, Grhta, vol. 8, no. 1, pp. 120–130, Sep. 2021.